4506 ORAL A large open-label, non-comparative, phase III study of the multi-targeted kinase inhibitor sorafenib in European patients with advanced renal cell carcinoma

✍ Scribed by Beck, J.; Bajetta, E.; Escudier, B.; Negrier, S.; Keilholz, U.; Szczylik, C.; Mersmann, S.; Burock, K.; Erlandsson, F.; Huber, C.

• Book ID: 123515807
• Publisher: Elsevier Science
• Year: 2007
• Tongue: English
• Weight: 59 KB
• Volume: 5
• Category: Article
• ISSN: 1359-6349
• DOI: 10.1016/S1359-6349(07)71137-0